Crizanlizumab

MedChem Express

Crizanlizumab

14

Research Use Only

Monoclonal

95.0

Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease[1][2][3].

2°C to 8°C

12352203